AxoGen, Inc. (AXGN) vs Establishment Labs Holdings Inc. (ESTA)
AxoGen, Inc. and Establishment Labs Holdings Inc. are both Medical Devices companies. AxoGen, Inc. is the larger, with a market value of $2.5B against $2.0B — 1.3× the size. Establishment Labs Holdings Inc. grew revenue faster over the last twelve months: 38.6% against 23.6%. AxoGen, Inc. has the higher net margin (−13.4% vs −15.8%) and the higher return on invested capital (−4.99% vs −5.53%). Across the 18 metrics below, AxoGen, Inc. leads on 12 and Establishment Labs Holdings Inc. on 6.
Valuation
Profitability
| Metric | AXGN | ESTA | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.56% | 70.49% | 56.01% |
| Operating margin | (5.12%) | (7.63%) | (15.03%) |
| Net margin | (13.36%) | (15.82%) | (20.40%) |
| Free cash flow margin | 2.59% | (16.90%) | (7.24%) |
| Return on equity | (18.21%) | (175.30%) | (15.32%) |
| Return on assets | (13.15%) | (11.41%) | (19.72%) |
| Return on invested capital | (4.99%) | (5.53%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack